Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

HUMACYTE, INC. — Lobbying — Receipts Report

LD-2 disclosure · 3rd Quarter - Report

HUMACYTE, INC.

via LINCOLN POLICY GROUP

3rd Quarter (July 1 - Sep 30) · 2020Posted Oct 20, 2020Filing document ↗LDA record ↗

Income$50Kfee reported

Client

Name: HUMACYTE, INC.
Description: Regenerative medical technology company
Location: North Carolina · United States of America

Registrant

Firm: LINCOLN POLICY GROUP
Description: Government affairs consulting
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Medicare/Medicaid
Access to regenerative medical technologies.
LobbyistsRUDY MISSMAR · COLIN ROSKEY · THOMAS A SCULLY
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.